炎症性阻塞性睑板腺功能障碍引发眼表炎症
睑板腺功能障碍(MGD)是蒸发过强型干眼的主要原因,睑脂淤滞导致泪膜不稳定和角膜浅层点状病变。MGD可伴发睑板腺炎,与角膜细胞浸润、新生血管等眼表炎症密切相关。临床应将睑板腺与眼表视为一个整体(MOS)来诊治,针对睑板腺炎症的治疗可能更合理。
要点
- MGD睑脂淤滞致泪膜不稳定,引起下角膜SPK和下球结膜点状染色。
- 睑板腺炎与角膜细胞浸润、新生血管、SPK和结膜炎等眼表炎症相关。
- 仅按干眼治疗SPK可能无效,需识别睑板腺炎并全身抗菌治疗。
核心结论
- 睑板腺炎相关的眼表炎症应作为睑板腺与眼表(MOS)整体来认识和治疗。
- 针对睑板腺炎症的治疗可能是睑板腺炎相关角结膜炎更合理的策略。
研究设计与样本
- 本文为叙述性综述,未报告系统检索范围或样本量。
主要发现
- 睑脂淤滞导致泪膜不稳定,表现为泪膜破裂时间缩短和下角膜SPK。
- 睑板腺和睫毛区细菌增殖可伴发睑板腺炎,与角膜细胞浸润和新生血管相关。
- 干眼所致SPK与睑板腺炎所致SPK难以区分。
- 仅用干眼专用滴眼液或保守无效时用泪点栓,可能无法缓解睑板腺炎所致SPK。
关键数值与推荐
- 识别睑板腺炎并给予全身抗菌药物治疗,可能改善此前干眼治疗无效的SPK。
临床怎么用
- 面对下角膜SPK和点状结膜染色时,应同时评估睑板腺有无炎症。
- 干眼常规治疗无效时,需考虑睑板腺炎并按MOS整体思路处理。
局限性
- 本文为综述,未报告原始研究数据、样本量或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Meibomian gland dysfunction (MGD) is one of the primary causes of evaporative dry eye. Stagnation of meibum induces an unstable tear film, thus resulting in shortened tear film breakup time and superficial punctate keratopathy (SPK) in the lower cornea and punctate staining of lower bulbar conjunctiva. MGD is sometimes accompanied with inflammation (termed "meibomitis") via the proliferation of bacteria in the meibomian gland and eyelash area. Meibomitis is strongly related to ocular surface inflammation such as corneal cellular infiltrates and neovascularization, SPK, and conjunctivitis. It is difficult to differentiate SPK caused by dry eye from that caused by meibomitis. When clinicians are unaware of the existence of meibomitis, and only aware of SPK on the cornea, they often try to treat SPK as it is caused by dry eye using dry eye-specific eyedrops or even using punctual plugs when conservative therapy is ineffective. However, even when intensive dry eye therapy is applied, it may be unsuccessful until SPK caused by meibomitis is recognized and treated with systemic antimicrobial agents. Hence, the tear secreting glands, including the meibomian glands, and the ocular surface should be clinically considered as one unit (i.e., the meibomian gland and ocular surface [MOS]) when considering the pathophysiology and treatment of ocular surface inflammatory diseases (i.e., corneal epithelial damage). Following this clinical pathway, a treatment focusing on meibomian gland inflammation may be a more reasonable approach for meibomitis-related or associated keratoconjunctivitis to more effectively treat this ocular surface disease.
引用
- Suzuki T. Inflamed Obstructive Meibomian Gland Dysfunction Causes Ocular Surface Inflammation. Invest Ophthalmol Vis Sci. 2018. PMID: 30481812. doi:10.1167/iovs.17-23345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。